中泰证券股份有限公司关于山东国子软件股份有限公司 使用募集资金置换已投入募投项目自有资金之核查意见 中泰证券股份有限公司（以下简称"中泰证券"或"保荐机构"）作为山东 国子软件股份有限公司（以下简称"公司"或"国子软件"）向不特定合格投资 者公开发行股票的保荐机构，根据《证券发行上市保荐业务管理办法》《北京证 券交易所证券发行上市保荐业务管理细则》《北京证券交易所股票上市规则》《北 京证券交易所上市公司持续监管办法（试行）》等相关规定，对使用募集资金置 换已投入募投项目自有资金的事项进行了审慎核查，具体如下： 一、募集资金基本情况 2023 年 7 月 20 日，公司收到中国证券监督管理委员会《关于同意山东国子 软件股份有限公司向不特定合格投资者公开发行股票注册的批复》（证监许可 [2023]1587 号），同意公司向不特定合格投资者公开发行股票的注册申请。公司 本次发行价格为 10.50 元/股，初始发行股数为 22,150,000 股（未考虑超额配售选 择权的情况下），在初始发行规模 22,150,000 股的基础上全额行使超额配售选择 权新增发行股票数量 3,322,500 股，由此发行总股数扩大至 2 ...

证券代码：920953 证券简称：国子软件 公告编号：2025-131 山东国子软件股份有限公司 关于使用募集资金置换已投入募投项目自有资金的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 山东国子软件股份有限公司于 2025 年 11 月 4 日召开第四届董事会第十九 次会议，审议通过了《关于公司使用募集资金置换已投入募投项目自有资金的议 案》，同意公司使用募集资金置换已投入募投项目自有资金。现将有关情况公告 如下： 2023 年 7 月 20 日，公司收到中国证券监督管理委员会《关于同意山东国子 软件股份有限公司向不特定合格投资者公开发行股票注册的批复》（证监许可 [2023]1587 号），同意公司向不特定合格投资者公开发行股票的注册申请。公司 本次发行价格为 10.50 元/股，初始发行股数为 22,150,000 股（未考虑超额配售 选择权的情况下），在初始发行规模 22,150,000 股的基础上全额行使超额配售 选择权新增发行股票数量3,322,500股，由此发行总股数扩大至25,4 ...

Market Overview - The A-share market is experiencing a high-level adjustment, with the Shanghai Composite Index closing at 3954.79 points, down 0.81%, and the Shenzhen Component Index at 13378.21 points, down 1.14% [2] - The total trading volume in the Shanghai and Shenzhen markets was 231.78 billion yuan, a decrease of approximately 100 billion yuan compared to the previous trading day [2] North Exchange Performance - The North Exchange 50 Index rose by 1.89% yesterday and has accumulated a 7.52% increase this week, significantly outperforming the major indices in the Shanghai and Shenzhen markets [2][6] - Notable stocks in the North Exchange include Fujida, which increased by 39.40% this week, and other companies like Better Battery and Tianma New Materials, which rose over 20% [6] - A total of 27 companies listed on the North Exchange reported revenues exceeding 1 billion yuan in the first three quarters, indicating strong performance across both established and emerging firms [6] Innovation Drug Sector - The innovation drug sector in A-shares saw a collective recovery, with companies like Sanofi and Shuyou Shen reaching a 20% limit-up, and others like Kangzhi Pharmaceutical and Zexin Pharmaceutical rising over 15% [3] - The Shenwan Pharmaceutical and Biological Index increased by 2.42%, leading all industry sectors [3] - According to CITIC Securities, government policies have been supportive of the development of innovative drugs and medical devices, focusing on research support, commercial health insurance directories, price formation mechanisms, and application support [3] AI Sector Dynamics - The AI sector showed significant internal differentiation, with hardware directions like AI servers experiencing declines, while downstream application sectors, particularly cultural media, saw substantial gains [4] - Institutional investors' positions in technology stocks reached 40.16% by the end of the third quarter, indicating a high level of investment in this sector [4] - The potential for a significant style shift in the market is increasing, as the current high level of institutional holdings in technology stocks may lead to changes in investment strategies [4] TMT Sector Insights - The TMT sector has grown to encompass over 1,000 companies, with a free float market capitalization exceeding 25%, allowing for increased capital inflow [5] - The next five years are expected to be crucial for advancing towards a technology-driven economy, potentially solidifying market consensus on technology growth trends [5] Future Outlook for North Exchange - The North Exchange is expected to maintain high trading activity and market attention due to steady new stock issuances and more merger and acquisition projects [7]

Market Overview - On October 31, the total trading volume of individual stocks on the Beijing Stock Exchange reached 1.299 billion shares, with a total trading value of 32.323 billion yuan, a decrease of 10.622 billion yuan compared to the previous trading day [1] - Among the tradable stocks, 219 stocks closed higher, accounting for 78.49% of the total, with notable gainers including Lijia Technology, Deyuan Pharmaceutical, and Sanyuan Gene, which rose by 13.91%, 13.09%, and 13.07% respectively [1] - Conversely, 55 stocks closed lower, with Huifeng Diamond, Jiuling Technology, and Meizhigao experiencing declines of 6.34%, 4.96%, and 4.57% respectively [1] Trading Activity - A total of 93 stocks had trading volumes exceeding 100 million yuan, with the highest trading values recorded for Beiterui, Fujida, and Guozi Software at 1.359 billion yuan, 999.5 million yuan, and 710 million yuan respectively [1] - The trading activity showed that 46 stocks had a turnover rate exceeding 10%, with 8 stocks exceeding 20%. Additionally, 73 stocks had turnover rates between 5% and 10%, while 159 stocks had turnover rates between 1% and 5% [1] Notable Stocks - Beiterui closed at 36.45 yuan with a rise of 4.71% and a turnover rate of 3.29%, with a trading value of approximately 1.359 billion yuan [1] - Guozi Software saw a significant increase of 11.75% to close at 44.70 yuan, with a turnover rate of 26.35% and a trading value of around 710 million yuan [1] - Deyuan Pharmaceutical closed at 41.30 yuan, up 13.09%, with a turnover rate of 12.64% and a trading value of approximately 523 million yuan [1] Summary of Trading Data - The trading data indicates a robust market activity with a significant number of stocks experiencing notable price movements and trading volumes, reflecting investor sentiment and market dynamics [1][2][3]

Summary of Key Points Core Viewpoint - On October 31, the Beijing Stock Exchange (BSE) saw a total trading volume of 1.299 billion shares and a trading value of 32.323 billion yuan, representing a decrease of 10.622 billion yuan compared to the previous trading day. A total of 219 stocks closed higher, indicating a positive market sentiment despite the drop in trading volume [1]. Trading Performance - The trading volume for the BSE was 1.299 billion shares, with a trading value of 32.323 billion yuan, down from the previous day by 10.622 billion yuan [1]. - Among the traded stocks, 219 stocks rose, accounting for 78.49% of the total, with notable gainers including Lijia Technology (up 13.91%), Deyuan Pharmaceutical (up 13.09%), and Sanyuan Gene (up 13.07%) [1]. - Conversely, 55 stocks declined, with Huifeng Diamond, Jiuling Technology, and Mezhigao experiencing the largest drops of 6.34%, 4.96%, and 4.57% respectively [1]. Active Stocks - A total of 93 stocks had a trading value exceeding 100 million yuan, with the highest trading values recorded for Beiterui (1.359 billion yuan), Fujida (999.5 million yuan), and Guozi Software (709.8 million yuan) [1]. - The trading activity was characterized by 46 stocks having a turnover rate exceeding 10%, with 8 stocks exceeding 20%. The highest turnover rates were seen in Digital Human (32.55%), Jinhua New Materials (28.91%), and Taikai Ying (27.85%) [1]. Notable Stock Details - Key stocks and their performance included: - Beiterui: Closing price 36.45 yuan, up 4.71%, turnover rate 3.29%, trading value 1.359 billion yuan [1]. - Guozi Software: Closing price 44.70 yuan, up 11.75%, turnover rate 26.35%, trading value 709.8 million yuan [1]. - Deyuan Pharmaceutical: Closing price 41.30 yuan, up 13.09%, turnover rate 12.64%, trading value 523.0 million yuan [1].

Market Overview - The A-share market experienced an overall decline on October 31, with the Shanghai Composite Index closing at 3954.79 points, down 0.81%, the Shenzhen Component Index at 13378.21 points, down 1.14%, and the ChiNext Index at 3187.53 points, down 2.31%. The North Star 50 Index increased by 1.89% [1] - Total trading volume in the A-share market was 23501.16 billion, a decrease of 1144.6 billion compared to the previous trading day [1] Capital Flow - The main capital outflow from the A-share market was 437.44 billion, with an opening net outflow of 120.47 billion and a closing net outflow of 90.52 billion [2] - The CSI 300 index saw a net outflow of 255.4 billion, while the ChiNext and STAR Market experienced net outflows of 162.56 billion and 57.19 billion, respectively [4] Sector Performance - The pharmaceutical and biotechnology sector led with a net inflow of 155.42 billion, marking a 2.72% increase [6][7] - Other sectors with significant inflows included media (96.02 billion, up 2.98%), computer (92.13 billion, up 1.81%), food and beverage (38.11 billion, up 1.49%), and retail (25.35 billion, up 1.55%) [7] - Conversely, the electronics sector faced the largest outflow at 278.68 billion, down 0.73%, followed by non-ferrous metals at 128.48 billion, down 1.03% [7] Institutional Activity - Oriental Precision Engineering saw the highest net inflow of 12.45 billion [8] - Institutions were active in several stocks, with notable net purchases in Zejing Pharmaceutical (206.78 million) and Shutai Shen (198.10 million) [10][11] Stock Recommendations - Recent institutional focus includes China Life Insurance with a target price of 10.40, indicating a potential upside of 23.22% from the latest closing price [12] - Other stocks with buy ratings include Shanghai Bank (target price 12.02, upside 26.66%) and Yuyue Medical (target price 45.47, upside 26.20%) [12]

Core Viewpoint - Guozi Software (920953) experienced a significant increase of 11.75% in its stock price, with a trading volume of 710 million yuan and a turnover rate of 26.35% on the day of reporting [1] Trading Activity - The stock's turnover rate of 26.35% led to its listing on the North Exchange's watchlist, indicating heightened trading activity [1] - Institutional investors net bought 6.9063 million yuan worth of shares, while brokerage seats collectively net sold 4.3921 million yuan [1] - The top five trading departments accounted for a total transaction volume of 114 million yuan, with a net buying amount of 2.5142 million yuan [1] Specific Trading Details - The top buying and selling departments included: - Buy One: Guojin Securities Shenzhen Branch with a buying amount of 13.6014 million yuan and selling amount of 2.2615 million yuan [1] - Buy Two: Institutional Special Seat with a buying amount of 10.9235 million yuan and selling amount of 4.0172 million yuan [1] - Buy Three: Guoxin Securities Shenzhen Internet Branch with a buying amount of 9.7262 million yuan and selling amount of 9.5054 million yuan [1] - The selling activities were led by: - Sell One: China Zhongjin Wealth Securities Haikou Longhua Road Branch with a selling amount of 13.2885 million yuan and a buying amount of 5.42 million yuan [1] - Sell Two: Guoxin Securities Shenzhen Internet Branch with a selling amount of 9.5054 million yuan [1]

【振幅大】 -今日A股共有8只个股振幅超过20%； -力佳科技、国子软件、海峡创新等个股振幅居前； 【换手率高】 -海科新源、超颖电子、海峡创新等个股换手率居前； 【主力资金】 -主力资金今日净流入传媒、医药生物、公用事业等板块，净流出电子、通信、电力设备等板块； -东方精工、长盈精密、三六零、蓝色光标、恩捷股份资金净流入规模居前，分别净流入12.45亿元、 7.19亿元、7.03亿元、6.92亿元、6.23亿元； -胜宏科技、中际旭创、新易盛、浪潮信息、立讯精密资金净流出规模居前，分别净流出30.72亿元、 25.49亿元、22.35亿元、17.49亿元、16.84亿元。 -今日A股共有21只个股换手率超过30%； ...

Market Overview - On October 31, major indices collectively declined, with the Shanghai Composite Index down 0.63% and the ChiNext Index down 1.49% [1] - The total trading volume in the Shanghai and Shenzhen markets reached 1.58 trillion yuan, an increase of 27.4 billion yuan compared to the previous trading day [1] - A total of 3,826 stocks rose while 1,497 stocks fell [1] Index Performance - The Shenzhen Component Index and Shanghai Composite Index saw declines of 0.63% and 0.62% respectively, while the North Exchange 50 Index rose over 3% [2] - The ChiNext Index fell by 1.49%, and the STAR Market 50 Index decreased by 2.51% [2] - The total trading volume was 1.58 trillion yuan, with a predicted volume of 2.47 trillion yuan, reflecting an increase of 6.2 billion yuan [2] Sector Performance - The pharmaceutical sector showed resilience, with stocks like Sanofi and Lianhuan Pharmaceutical hitting the daily limit [2] - The lithium battery sector was active, with Tianji shares achieving consecutive gains and several stocks reaching the daily limit [2] - In contrast, computing hardware concept stocks experienced significant declines, particularly in the optical module sector [3] Hong Kong Market - The Hang Seng Index and Hang Seng Tech Index both declined, with notable drops in stocks like China CRRC and BYD [3][4] - The biotechnology and healthcare sectors showed strength despite the overall market downturn [3] Gold Market - As of October 31, the price of gold jewelry per gram returned to 1,200 yuan, with brands like Chow Sang Sang and Lao Feng Xiang reporting increases [7][10] - The gold market is experiencing high-frequency fluctuations, with banks adjusting investment thresholds to align with market dynamics [10] - Analysts remain optimistic about the gold market's outlook due to factors such as a weakening dollar and expectations of interest rate cuts [10]

Market Overview - On October 31, major indices collectively declined, with the Shanghai Composite Index down 0.63% and the ChiNext Index down 1.49% [1] - The trading volume in the Shanghai and Shenzhen markets reached 1.58 trillion yuan, an increase of 27.4 billion yuan compared to the previous trading day [1] - A total of 3,826 stocks rose while 1,497 stocks fell [1] Sector Performance - The North Exchange 50 Index surged over 3%, with companies like Lijia Technology, Betterray, and KunGong Technology each rising over 10% [1] - The pharmaceutical sector saw gains, with Sanofi and Lianhuan Pharmaceutical hitting the daily limit [1] - The lithium battery sector was active, with Tianji shares achieving two consecutive limits and several stocks like Enjie shares also hitting the daily limit [1] Regional Stocks - Fujian local stocks performed well, with Pingtan Development achieving eight limits in eleven days, and other stocks like Fulongma and Fujian Jinsen also gaining [1] Declining Stocks - The computing hardware concept stocks collectively fell, with major adjustments in the "Yizhongtian" optical module trio [1] - Storage chip concept stocks experienced volatility, with Jiangbolong dropping over 10% [1] - Controlled nuclear fusion concept stocks declined, with China Nuclear Construction hitting the daily limit down [1] Hong Kong Market - The Hang Seng Index and Hang Seng Tech Index both showed declines, while biotechnology and healthcare sectors strengthened [2] - Notable declines included China CNR down nearly 9% and BYD down over 5% [2] Japanese Market - The Nikkei 225 Index reached a historical high, surpassing 52,000 points, before retreating slightly to 51,948.26 points, with a gain of 1.21% [2] - Leading sectors included semiconductors, consumer goods, and electricity, with Hitachi rising over 8% [2] Gold Market - Spot gold rose 2.37% in New York trading, but saw a slight decline in early trading in Beijing, falling below the 4,000 yuan mark [2] - Domestic gold jewelry prices returned to around 1,200 yuan per gram, with brands like Chow Sang Sang and Lao Feng Xiang showing daily increases [2] Gold Investment Outlook - The World Gold Council's market analyst expressed an optimistic outlook for the gold market, citing a weakening dollar, general expectations of interest rate cuts, and stagflation risks as supportive factors for gold investment demand [3] - The current market environment suggests that gold still has potential for further upward movement, with strategic value in gold allocation remaining solid [3]